查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1474864

表观遗传学市场规模、份额、趋势分析报告：按产品、按技术、按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments), By Technology (DNA Methylation), By Application (Oncology), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

表观遗传学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球表观遗传学市场规模将达到391.5亿美元，2024年至2030年复合年增长率为15.3%。

该市场的推动因素包括表观遗传学研究和开发的资金筹措、投资和监管审批的增加、表观遗传酶在药物发现和开发中的使用的扩大以及基因组序列测定成本的降低。随着表观遗传学已证明其在肿瘤学之外的有益应用，预计将实现商业性扩张。对在分子层面上了解表观遗传变化和药物治疗进步的需求不断增长，可能会推动这些组织支持研究和开发计画。

此外，流行病学和基因组学研究计划 (EGRP) 等倡议奖励了旨在更好地了解肿瘤发展和结果的研究工作。推动市场成长的一些组织包括国际人类表观基因联盟(IHEC)、美国癌症研究所 (NCI) 和美国国立卫生研究院 (NIH)。这些组织资助和支持包括表观遗传学领域的产品开发和研究与开发在内的倡议。例如，美国国立卫生研究院透过通用基金表观基因计划，在全球范围内积极推动尖端表观遗传学研究。

表观遗传学市场报告亮点

  • 从产品来看，试剂细分市场占据主导地位，2023年占全球收益的33.45%。此细分市场的主要份额归因于表观遗传学研究中试剂的高使用率。
  • 从技术来看，DNA甲基化细分市场占据主导地位，2023年销售份额为45.36%。表观遗传学对DNA甲基化的需求源自于其在调节基因表现中的关键角色。
  • 从应用来看，肿瘤学占据市场主导地位，2023 年销售份额为 69.06%。肿瘤对錶观遗传学的需求源自于表观遗传学变化与癌症发展之间的复杂关係。
  • 北美市场占据主导地位，2023 年市占率为 38.19%。由于公众意识的提高、医疗设施的改善以及大量的研发投资，该地区正在经历成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章表观遗传学市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
    • 市场机会分析
  • 表观遗传学市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章表观遗传学市场：产品评估与趋势分析

  • 细分仪表板
  • 全球表观遗传学市场产品趋势分析
  • 2018-2030年全球表观遗传学市场规模与趋势分析（按产品）
  • 试剂
  • 套件
  • 装置
  • 酵素
  • 服务

第五章表观遗传学市场：技术评估与趋势分析

  • 细分仪表板
  • 全球表观遗传学市场技术趋势分析
  • 2018-2030 年全球表观遗传学市场规模与趋势分析（按技术）
  • DNA甲基化
  • 组蛋白甲基化
  • 组蛋白乙酰化
  • 大非编码RNA
  • 微型RNA修饰
  • 染色质结构

第六章表观遗传学市场：应用估算与趋势分析

  • 细分仪表板
  • 全球表观遗传学市场应用趋势分析
  • 2018-2030 年全球表观遗传学市场规模与趋势分析（按应用）
  • 瘤
  • 非肿瘤

第七章表观遗传学市场：最终用途估计与趋势分析

  • 细分仪表板
  • 全球表观遗传学市场最终用途趋势分析
  • 2018-2030 年全球表观遗传学市场规模与趋势分析（依最终用途）
  • 学术研究
  • 临床研究
  • 医院/诊所
  • 製药和生物技术公司
  • 其他的

第八章表观遗传学市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模与预测/趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Eisai Co., Ltd.
    • Novartis AG
    • ELEMENT BIOSCIENCES.
    • Dovetail Genomics.
    • Illumina, Inc.
    • Promega Corporation
    • Abcam plc
Product Code: 978-1-68038-583-0

Epigenetics Market Growth & Trends:

The global epigenetics market size is expected to reach USD 39.15 billion by 2030, registering a CAGR of 15.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is being driven by factors, such as the rise in funding, investment & regulatory approvals for epigenetics research & development, the expansion of the use of epigenetic enzymes in drug discovery & development, and the decreasing cost of genome sequencing. Since epigenetics has demonstrated beneficial applications outside of cancer, commercial expansion is envisaged.The rising demand for understanding epigenetic alterations at the molecular level, as well as the advancement of medicinal treatments, would likely push these organizations to support research and development programs.

Furthermore, initiatives, such as the Epidemiology and Genomics Research Program (EGRP), provide incentives for research efforts aimed at better-comprehending cancer genesis and consequences.A few organizations that help fuel the market's rise are the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institutes of Health (NIH). These organizations support funding and help for initiatives involving product development and R&D in the field of epigenetics. For instance, the National Institutes of Health aggressively promotes cutting-edge epigenetic research worldwide through its common fund epigenomics program.

Epigenetics Market Report Highlights:

  • By product, the reagents segment dominated the industry, accounting for 33.45% of the global revenue in 2023. The large share of this segment can be attributed to the high usage of reagents in epigenetic research studies.
  • By technology, the DNA methylation segment dominated the market with a revenue share of 45.36% in 2023. DNA methylation's demand in epigenetics stems from its pivotal role in gene expression regulation.
  • By application, the oncology segment dominated the market with a revenue share of 69.06% in 2023. Oncology's demand for epigenetics arises from the intricate relationship between epigenetic alterations and cancer development.
  • North America dominated the market and accounted for a 38.19% share in 2023. The region experiences growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective - 1
    • 1.10.2. Objective - 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Epigenetics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Rising geriatric patient population
      • 3.2.1.3. Increasing government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of standardization in epigenetics-based diagnostics
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improving healthcare infrastructure in developing economies
  • 3.3. Epigenetics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Epigenetics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Epigenetics Market Product Movement Analysis
  • 4.3. Global Epigenetics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Kits
    • 4.5.1. Kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. ChIP sequencing Kit
      • 4.5.2.1. ChIP sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Whole Genomic Amplification Kit
      • 4.5.3.1. Whole genomic amplification kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Bisulfite Conversion Kit
      • 4.5.4.1. Bisulfite conversion kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. RNA sequencing Kit
      • 4.5.5.1. RNA sequencing kit market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Instruments
    • 4.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Services
    • 4.8.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Epigenetics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Epigenetics Market Technology Movement Analysis
  • 5.3. Global Epigenetics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. DNA Methylation
    • 5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Histone Methylation
    • 5.5.1. Histone methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Histone Acetylation
    • 5.6.1. Histone Acetylation Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Large non-coding RNA
    • 5.7.1. Large non-coding RNA market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MicroRNA modification
    • 5.8.1. MicroRNA modification market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Chromatin structures
    • 5.9.1. Chromatin structures market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Epigenetics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Epigenetics Market Application Movement Analysis
  • 6.3. Global Epigenetics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Solid tumors
      • 6.4.2.1. Solid tumors market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Liquid tumors
      • 6.4.3.1. Liquid tumors market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Non-oncology
    • 6.5.1. Non-oncology Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Inflammatory diseases
      • 6.5.2.1. Inflammatory diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Metabolic diseases
      • 6.5.3.1. Metabolic diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Infectious diseases
      • 6.5.4.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Cardiovascular diseases
      • 6.5.5.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Others
      • 6.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Epigenetics Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Epigenetics Market End-use Movement Analysis
  • 7.3. Global Epigenetics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 7.4. Academic Research
    • 7.4.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Research
    • 7.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Hospitals & Clinics
    • 7.6.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Pharmaceutical & Biotechnology Companies
    • 7.7.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Other Users
    • 7.8.1. Other users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Epigenetics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Target disease prevalence
      • 8.4.2.4. Competitive scenario
      • 8.4.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Target disease prevalence
      • 8.4.3.4. Competitive scenario
      • 8.4.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Target disease prevalence
      • 8.5.2.4. Competitive scenario
      • 8.5.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Target disease prevalence
      • 8.5.3.4. Competitive scenario
      • 8.5.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Target disease prevalence
      • 8.5.4.4. Competitive scenario
      • 8.5.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Target disease prevalence
      • 8.5.5.4. Competitive scenario
      • 8.5.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Target disease prevalence
      • 8.5.6.4. Competitive scenario
      • 8.5.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Target disease prevalence
      • 8.5.7.4. Competitive scenario
      • 8.5.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Target disease prevalence
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Competitive scenario
      • 8.5.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Target disease prevalence
      • 8.5.9.4. Competitive scenario
      • 8.5.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Target disease prevalence
      • 8.6.2.4. Competitive scenario
      • 8.6.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Target disease prevalence
      • 8.6.3.4. Competitive scenario
      • 8.6.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Target disease prevalence
      • 8.6.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Target disease prevalence
      • 8.6.5.4. Competitive scenario
      • 8.6.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Target disease prevalence
      • 8.6.6.4. Competitive scenario
      • 8.6.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Target disease prevalence
      • 8.6.7.3. Regulatory framework
      • 8.6.7.4. Competitive scenario
      • 8.6.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Target disease prevalence
      • 8.7.2.4. Competitive scenario
      • 8.7.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Target disease prevalence
      • 8.7.3.4. Competitive scenario
      • 8.7.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Target disease prevalence
      • 8.7.4.4. Competitive scenario
      • 8.7.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Target disease prevalence
      • 8.8.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Target disease prevalence
      • 8.8.3.4. Competitive scenario
      • 8.8.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Target disease prevalence
      • 8.8.4.4. Competitive scenario
      • 8.8.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Target disease prevalence
      • 8.8.5.4. Competitive scenario
      • 8.8.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Thermo Fisher Scientific Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Eisai Co., Ltd.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Novartis AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. ELEMENT BIOSCIENCES.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Dovetail Genomics.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Illumina, Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Promega Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Abcam plc
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global epigenetics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Europe epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Germany epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 34 France epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 France epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 36 France epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Italy epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Spain epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Norway epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 China epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 63 China epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 64 China epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 China epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 71 India epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 India epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 73 India epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Thailand epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Latin America epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Brazil epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Mexico epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA epigenetics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE epigenetics market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait epigenetics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait epigenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait epigenetics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait epigenetics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Epigenetics market: Market outlook
  • Fig. 5 Epigenetics market: Segment outlook
  • Fig. 6 Epigenetics market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Epigenetics market driver impact
  • Fig. 9 Epigenetics market restraint impact
  • Fig. 10 Epigenetics market: Product outlook and key takeaways
  • Fig. 11 Epigenetics market: Product movement analysis
  • Fig. 12 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 ChIP sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Whole genomic amplification kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Bisulfite conversion kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 RNA sequencing kit market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Epigenetics market: Technology outlook and key takeaways
  • Fig. 23 Epigenetics market: Technology movement analysis
  • Fig. 24 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Histone methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Histone acetylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Large non-coding RNA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 MicroRNA modification market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Chromatin structures market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Epigenetics market: Application outlook and key takeaways
  • Fig. 31 Epigenetics market: Application movement analysis
  • Fig. 32 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Solid tumors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Liquid tumors market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 35 Non-oncology market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 36 Inflammatory diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Metabolic diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 38 Infectious diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Cardiovascular diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Epigenetics market: End-use outlook and key takeaways
  • Fig. 42 Epigenetics market: End-use movement analysis
  • Fig. 43 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Clinical research market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 45 Hospitals & Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 47 Other users market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Global epigenetics market: Regional outlook and key takeaways
  • Fig. 49 Global epigenetics market: Regional movement analysis
  • Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)